High-dose aspirin is associated with anemia and does not confer benefit to disease outcomes in Kawasaki disease

Ho Chang Kuo, Mao Hung Lo, Kai Sheng Hsieh, Mindy Ming Huey Guo, Ying Hsien Huang

Research output: Contribution to journalJournal Article peer-review

61 Scopus citations

Abstract

Background Kawasaki disease (KD) is also known as multiple mucocutaneous lymph node syndrome of systemic vasculitis and is a leading cause of coronary artery lesions (CAL) in childhood. Intravenous immunoglobulin (IVIG) has been proven to effectively reduce the incidence of CAL, but the role and effect dose of aspirin in KD is still unclear. Moreover, overt bleeding and anemia are associated with the use of aspirin, and anemia is common in patients with KD. Thus, the aim of this study was conducted to compare the treatment efficacy, degree of anemia and inflammation, and changes in serum hepcidin in children who received a combination of high-dose aspirin and IVIG in the acute stage of KD, and those who received IVIG alone.

Original languageEnglish
Article numbere0144603
JournalPLoS ONE
Volume10
Issue number12
DOIs
StatePublished - 01 12 2015

Bibliographical note

Publisher Copyright:
© 2015 Kuo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Fingerprint

Dive into the research topics of 'High-dose aspirin is associated with anemia and does not confer benefit to disease outcomes in Kawasaki disease'. Together they form a unique fingerprint.

Cite this